Please try another search
For the nine months ended 30 September 2019, Baytacare Pharmaceutical Co Ltd revenues increased from RMB13.2M to RMB63.1M. Net loss decreased 87% to RMB2.2M. Revenues reflect Trading Business segment increase from RMB7.1M to RMB41.7M, Big data business segment increase from RMB2.4M to RMB21.4M. Lower net loss reflects Big data business segment income totaling RMB1.7M vs. loss of RMB15.8M.
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Revenue | 55.88 | 0 | 7.21 | 18.72 |
Gross Profit | 4.13 | 0 | 0.69 | 1.72 |
Operating Income | 1.26 | -2.06 | -0.82 | -98.2 |
Net Income | 1.36 | -2.07 | -1.48 | -99.08 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Total Assets | 111.26 | 111.31 | ||
Total Liabilities | 112.95 | 109.45 | ||
Total Equity | -1.69 | 1.86 |
Period Ending: | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 |
---|---|---|---|---|
Period Length: | 0 Months | 6 Months | 0 Months | 12 Months |
Cash From Operating Activities | -2.65 | 5.49 | ||
Cash From Investing Activities | -1.54 | 0 | ||
Cash From Financing Activities | 0 | |||
Net Change in Cash | -4.19 | 5.49 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review